March 4-5 2026
San Diego Convention Center
Discovery • Development • Manufacturing • Fill & Finish • Market Access
-
March 4-5 2026
-
March 4-5 2026
San Diego Convention CenterDiscovery • Development • Manufacturing • Fill & Finish • Market Access
-
March 4-5 2026
San Diego Convention CenterDiscovery • Development • Manufacturing • Fill & Finish • Market Access
America’s Most Exciting Biologics Event
2,000
Attendees
300
Speakers
120
Exhibitors
50
Biotech Start-Ups
2
Days
What is the Festival of Biologics?
Conference
The start to finish of biologic drug development from discovery through to market access across 2 days and 11 tracks
Exhibition
120 leading solution providers to meet your needs across discovery, development, manufacturing, fill finish and market access
Networking
Connect with thousands of biologics experts in 12+ hours of built-in 1-2-1 networking
The start-to-finish of biologics
The Festival of Biologics brings together pharma & biotech, academics, research institutes, regulators, patients groups and payers together with their partners across the value chain to bring you from discovery to market.
America's most comprehensive biologics agenda
DISEASE AREAS
Oncology
Chronic and acute inflammation
Autoimmune diseases
Infectious diseases
Neurodegenerative diseases
THERAPIES
Antibody formats (mAbs, Bispecifics, ADCs)
Cell therapy
Gene therapy
Vaccines
Precision medicine
Checkpoint inhibition
Combination therapies
Biosimilars
DISCOVERY
Protein expression & discovery
Target identification
Lead screening
Optimisation methods
Antibody expression
AI for discovery
DEVELOPMENT
Protein engineering
Gene engineering
Analytics
Immunogenicity
AI and computational tools
CMC
Biomarkers
Tumor Microenvironment
Biosimilars
CLINICAL TRIALS OPERATIONS
Trial design
Patient recruitment
Digital/data systems
Site selection
Regulation
Real world evidence
AI
Wearables
MANUFACTURING
Upstream processing
Downstream processing
Formulation
Purification
Cell line development
Biosimilar manufacturing
FILL & FINISH AND LOGISTICS
Injectables
Aseptic fill
Freeze drying
Shipping systems
Global and local supply chain management
FINANCE AND INVESTMENT
Seed investment
Licensing
Mergers and acquisitions
VC and accelerator funding
Global investment landscape
COMMERCIALISATION AND MARKET ACCESS
Get to market
Regulatory environment
Biosimilar commercialisation
Market sustainability
DIAGNOSTICS
Companion Diagnostics
Molecular Diagnostics
Biomarker Analysis
In Vivo Techniques
Diagnostic Devices
Our 2025 Speaker Line-Up
Jonas Helma-Smets
CSO
Tubulis
CSO
Tubulis
Sandeep Athalye
Chief Development Officer
Biocon Biologics
Chief Development Officer
Biocon Biologics
Attendees include
“Agenda was covering a wide spectrum of topics related to the field.”
- Molecular Biologist RGCC International GmbH
"The talks were very interesting and informative."
- Instructor, Baylor College of Medicine
”Good variety of speakers and subjects“
- Senior Scientist, Sanofi
- Senior Scientist, Sanofi
"A broad variety of exhibitions and talks; good balance of established companies, university and start-ups"
- Scientist, BioNTech
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events